Order Article Reprints

Reichert ZR, Kasputis T, Nallandhighal S, Abusamra SM, Kasputis A, Haruray S, Wang Y, Williams S, Singhal U, Alva A, et al. Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). International Journal of Molecular Sciences. 2022; 23(1):4. https://doi.org/10.3390/ijms23010004

Reichert, Zachery R., Tadas Kasputis, Srinivas Nallandhighal, Sophia M. Abusamra, Amy Kasputis, Saloni Haruray, Yugang Wang, Shamara Williams, Udit Singhal, Ajjai Alva, and et al. 2022. "Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)" International Journal of Molecular Sciences 23, no. 1: 4. https://doi.org/10.3390/ijms23010004

Reichert, Z. R., Kasputis, T., Nallandhighal, S., Abusamra, S. M., Kasputis, A., Haruray, S., Wang, Y., Williams, S., Singhal, U., Alva, A., Cackowski, F. C., Caram, M. E. V., Palmbos, P. L., Yentz, S. E., Smith, D. C., Alumkal, J. J., & Morgan, T. M. (2022). Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). International Journal of Molecular Sciences, 23(1), 4. https://doi.org/10.3390/ijms23010004